Mastercard Inc. (MA: Quote) is rising nearly 4 percent to $535.94. The company's fourth quarter profit surged from the previous year period. Net revenue for the quarter rose 10 percent.
Ericsson (ERIC: Quote) is up 11 percent to $11.82. The company swung to a loss in its fourth quarter, reflecting anticipated charge related to its joint venture ST-Ericsson. Adjusted earnings surged from last year on higher sales and margin.
WMS Industries Inc. (WMS) is jumping over 54 percent to $25.30. Scientific Games Corp. (SGMS) has agreed to acquire the company for $26.0 per share. SGMS is rising 13 percent to $10.12.
QUALCOMM Inc. (QCOM: Quote) is rising 7 percent to $67.85 following the release of its first quarter results.
Online Resources Corp. (ORCC: Quote) is surging 81 percent to $3.81 based on the news that ACI Worldwide (ACIW) has agreed to acquire the company in an all cash transaction for $3.85 per share.
Facebook, Inc. (FB: Quote) is down 6 percent to $29.35 following the release of its fourth quarter results.
Colgate-Palmolive Co. (CL: Quote) is falling more than 1 percent to $108.98. The company's fourth quarter profit improved from the prior year period and its non-GAAP earnings per share were above Wall Street view. Net sales increased 2.5 percent, but missed the consensus estimate.
Time Warner Cable Inc. (TWC: Quote) is sliding over 3 percent to $97.37. The company's fourth quarter earnings declined from the prior year period. Total revenue increased 9.9 percent, but marginally missed the consensus estimate. The company also its raised its regular quarterly dividend by 16 percent.
United Parcel Service, Inc. (UPS: Quote) is falling nearly 2 percent to $79.70. The company slipped to a loss in its fourth quarter, while adjusted earnings per share were below Wall Street view. Total revenue in the quarter rose 2.9 percent and topped the consensus estimate. The company forecast 2013 earnings per share below analysts' estimate.
Celsion Corp. (CLSN: Quote) is slumping 81 percent to $1.53. based on the news that ThermoDox in combination with radiofrequency ablation did not meet the primary endpoint of the Phase III HEAT Study in patients with hepatocellular carcinoma, also known as primary liver cancer.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org